Baillie Gifford Global Discovery Fund A AccumulationRegister to Unlock Ratings |
| Performance History | 31/05/2022 |
| Growth of 1,000 (GBP) | Advanced Graph |
 | Fund | 4.0 | 23.0 | 75.4 | -21.2 | -32.6 |
| +/-Cat | 14.6 | 4.1 | 62.1 | -37.7 | -22.7 |
| +/-B’mrk | 12.4 | 2.5 | 63.3 | -38.5 | -25.5 |
| Category: Global Small/Mid-Cap Equity | ||||||
| Category Benchmark: MSCI ACWI SMID NR USD | ||||||
| Key Stats | ||
| NAV 28/06/2022 | GBX 1320.00 | |
| Day Change | -0.75% | |
| Morningstar Category™ | Global Small/Mid-Cap Equity | |
| IA (formerly IMA) Sector | Global | |
| ISIN | GB0006059116 | |
| Fund Size (Mil) 28/06/2022 | GBP 1010.81 | |
| Share Class Size (Mil) 31/05/2022 | GBP 20.71 | |
| Max Initial Charge | - | |
| Ongoing Charge 31/05/2022 | 1.52% | |
| Morningstar Research |
| Analyst Report |
Baillie Gifford Global Discovery’s experienced manager and broad in-house resources, together with a unique approach, continue to support a Morningstar Analyst Rating of Silver for the B Acc share class. Ratings for other share classes range from... |
| Click here to read this analyst report on the underlying fund. |
| Morningstar Pillars | |
|---|---|
| People | Above Average |
| Parent | High |
| Process | Above Average |
| Performance | |
| Price | |
| Investment Objective: Baillie Gifford Global Discovery Fund A Accumulation |
| The Fund aims to outperform (after deduction of costs) the S&P Global Small Cap Index, as stated in Sterling, by at least 2% per annum over rolling five-year periods.The Fund will invest at least 90% in shares of companies. The Fund will be actively managed and will invest in shares of companies in any country and in any sector which typically at the time of initial purchase have a market capitalisation of US$10 billion or less and that the ACD considers will offer excellent future growth prospects. |
| Returns | |||||||||||||
|
| Management | ||
Manager Name Start Date | ||
Douglas Brodie 03/05/2011 | ||
Svetlana Viteva 01/01/2018 | ||
| Click here to see others | ||
Inception Date 03/05/2011 | ||
| Advertisement |
| Category Benchmark | |
| Fund Benchmark | Morningstar Benchmark |
| S&P Global Small TR USD | MSCI ACWI SMID NR USD |
| Target Market | ||||||||||||||||||||
| ||||||||||||||||||||
| Portfolio Profile for Baillie Gifford Global Discovery Fund A Accumulation | 30/04/2022 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| Top 5 Holdings | Sector | % |
 Alnylam Pharmaceuticals Inc |  Healthcare | 6.66 |
| Staar Surgical Co | Healthcare | 3.90 |
| Ocado Group PLC |  Consumer Defensive | 3.78 |
 Upwork Inc |  Industrials | 3.02 |
| NovoCure Ltd | Healthcare | 2.99 |
 | ||
Increase Decrease  New since last portfolio | ||
| Baillie Gifford Global Discovery Fund A Accumulation | ||
